Exelixis

Morrissey
Favicon Fierce Pharma

Exelixis aims to be a top 5 solid tumor drugmaker in the US: CEO

With phase 3 results for a potential new blockbuster on the horizon and a growing pipeline, Exelixis' CEO laid out his aspirations for the company.
Angus Liu Jan 16, 2026 1:00pm
reshuffle pipeline target reorganize shift change

ESMO: Exelixis' TKI reduces risk of death by 20%

Oct 20, 2025 2:30am
Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Exelixis plans shuttering of East Coast site, 130 layoffs

Aug 29, 2025 9:15am
Graphic image of an arrow nailing the bullseye of a target

Exelixis beats Bayer drug in cancer trial, sending stock higher

Jun 23, 2025 7:30am
image of two race cars neck and neck

Exelixis drops ADC after deciding it's no match for Tivdak

Aug 7, 2024 5:22am
layoffs cut staff reduction workforce

Exelixis lays off 175 employees in refocus on emerging pipeline

Jan 8, 2024 6:10am